Oxford tests One-Shot rabies vaccine combo in africa
NCT ID NCT07168018
Summary
This study is testing whether a new experimental rabies vaccine can be safely given at the same time as the standard licensed vaccine. Researchers want to see if this combination creates a strong immune response with fewer clinic visits. The trial will involve 40 healthy adults in Tanzania, comparing the new one-visit approach to the standard three-visit schedule.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ifakara Health Institute
Bagamoyo, Tanzania
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.